India's drug price regulator has capped retail prices for 53 drug formulations used in treating various diseases and conditions to ensure these medicines are affordable to the common public.

Several domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly ...

Last year, sales of tablet devices to consumers grew to 2.6 million units—up 24% since 2023, as per data shared with Mint by market researcher International Data Corporation (IDC) India.

New Delhi: India’s drug price regulator has capped the retail prices of 53 formulations or ... NPPA has fixed the retail price at ₹14.98 per tablet for a combination drug (acetylcysteine ...

In India, the Lenovo Idea Tab Pro is available in two storage variants. The base version comes with 8GB of RAM and 128GB of ...